Boss of Open Orphan volunteers for Covid-19 drug trial

Executive chairman of the Irish drug testing firm, Cathal Friel, wants to be part of study which involves being infected by the virus

Ian Guider

Markets Editor @ianguider

25th October, 2020

Boss of Open Orphan volunteers for Covid-19 drug trial

Cathal Friel, Open Orphan’s executive chairman, said he had volunteered to be among those involved in the study, although he would not be part of the first group

The head of Open Orphan, the Irish drug trials and testing company, has said he has volunteered to be infected with a dose of Covid-19 as part of a human study into the virus.

Open Orphan’s subsidiary hVIVO won a £40 million (€44 million) contract with the British government last week which will see it conduct what is termed a human challenge trial, that will involve volunteers being given a strain of Covid-19 to study...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine